Randomized controlled trial of combined 5-Fluorouracil and low-molecular-weight heparin in the management of unselected rhegmatogenous retinal detachments undergoing primary vitrectomy.
about
Transcriptomic analysis of human retinal detachment reveals both inflammatory response and photoreceptor deathIntravitreal low molecular weight heparin and 5-Fluorouracil for the prevention of proliferative vitreoretinopathy following retinal reattachment surgeryIntravitreal low molecular weight heparin and 5-Fluorouracil for the prevention of proliferative vitreoretinopathy following retinal reattachment surgerySteroids as an adjunct for reducing the incidence of proliferative vitreoretinopathy after rhegmatogenous retinal detachment surgery: a systematic review and meta-analysisProliferative vitreoretinopathy: current and emerging treatmentsIntrasilicone oil injection of bevacizumab at the end of retinal reattachment surgery for severe proliferative vitreoretinopathy.The fate of Müller's glia following experimental retinal detachment: nuclear migration, cell division, and subretinal glial scar formationInterleukin and growth factor levels in subretinal fluid in rhegmatogenous retinal detachment: a case-control study.Comparison of gene expression profile of epiretinal membranes obtained from eyes with proliferative vitreoretinopathy to that of secondary epiretinal membranesAntiproliferative property of hexadecyloxypropyl 9-[2-(phosphonomethoxy) ethyl] guanine (HDP-PMEG) for unwanted ocular proliferationOcular tolerance and efficacy of short-term tamponade with double filling of polydimethyloxane and perfluoro-n-octaneDeferred laser photocoagulation of relaxing retinotomies under silicone oil tamponade to reduce recurrent macular detachment in severe proliferative vitreoretinopathy.Protein changes in the retina following experimental retinal detachment in rabbits.Identification of inflammatory mediators in patients with rhegmatogenous retinal detachment associated with choroidal detachmentUnited Kingdom National Ophthalmology Database Study of Vitreoretinal Surgery: report 1; case mix, complications, and cataract.Adjunctive intraocular and peri-ocular steroid (triamcinolone acetonide) versus standard treatment in eyes undergoing vitreoretinal surgery for open globe trauma (ASCOT): study protocol for a phase III, multi-centre, double-masked randomised controlProliferative vitreoretinopathy after eye injuries: an overexpression of growth factors and cytokines leading to a retinal keloidPirfenidone inhibits migration, differentiation, and proliferation of human retinal pigment epithelial cells in vitro.Effects of resveratrol on ARPE-19 cell proliferation and migration via regulating the expression of proliferating cell nuclear antigen, P21, P27 and p38MAPK/MMP-9Inhibition of Proliferation and Epithelial Mesenchymal Transition in Retinal Pigment Epithelial Cells by Heavy Chain-Hyaluronan/Pentraxin 3.Mechanisms of inflammation in proliferative vitreoretinopathy: from bench to bedside.Minireview: Fibronectin in retinal disease.A novel cytarabine crystalline lipid prodrug: hexadecyloxypropyl cytarabine 3',5'-cyclic monophosphate for proliferative vitreoretinopathy.Hydrosilylated porous silicon particles function as an intravitreal drug delivery system for daunorubicin.5-Fluoro-Uracil and Low Molecular Weight Heparin in the Management of Proliferative Vitreo-retinopathy.Ozurdex (a slow-release dexamethasone implant) in proliferative vitreoretinopathy: study protocol for a randomised controlled trial.A novel lipid prodrug strategy for sustained delivery of hexadecyloxypropyl 9-[2-(phosphonomethoxy)ethyl]guanine (HDP-PMEG) on unwanted ocular proliferation.The role of alkylphosphocholines in retinal Müller glial cell proliferation.Irrigation with thapsigargin and various concentrations of 5-fluorouracil in a sealed-capsule irrigation device in young rabbit eyes to prevent after-cataract.Dabigatran inhibits intravitreal thrombin activity.Predicting proliferative vitreoretinopathy: temporal and external validation of models based on genetic and clinical variables.Triamcinolone during pars plana vitrectomy for open globe trauma: a pilot randomised controlled clinical trial.Timing and outcomes after silicone oil removal in proliferative vitreoretinopathy: a retrospective clinical series.
P2860
Q21134936-DD8280A0-9FB6-4A89-934A-2308F425AA3BQ24201611-D4D752D1-50FC-480A-ACCE-FC5928E34A68Q24234216-02C3BC3A-A58B-44D3-8772-AA40C3E831E6Q28086797-92D85020-33A8-4089-9B20-B73A29F060E0Q28274083-49CBE90F-DF2F-4B73-8A9D-11923597B96DQ33595120-08D6755E-86C6-474A-BF78-0883269CC889Q33642883-B5356838-0D12-4B28-9AF5-6022D4827F21Q33893886-CD997699-A45A-4370-97A9-3A8073C31D9BQ34571014-F87A39F8-4B61-4F7F-B66D-8573EC31B177Q34628633-C39FC593-E5CF-4671-BB2C-D25A2BC810C5Q34956613-B92B043E-7F3B-4D89-8C11-AA13513F0CDBQ35123278-26A55A53-7256-46AC-8F9E-F724E39B761DQ35531768-DBD49DAA-2637-4601-96FF-87E517F72257Q35645859-3DB87094-6829-4CCD-98F5-3AFD42929BF5Q36832268-DA96EE96-85F2-45AF-9A96-DC4EAB507730Q37118336-364E9B39-8AFF-4CE4-99D7-355390CE2814Q37250122-36C7A15A-06E7-4134-A6EC-BEA7EE020FB5Q37445130-A641B378-8581-4607-B3B5-7F2C4BBBDFF8Q37500491-E33D40C0-11C6-470A-A8A6-60E66A2623C1Q37676284-3C7AF6F7-B827-4EDF-8ABB-C3FCCF3BD972Q38050745-79EB988E-F0EC-469C-BCEA-3D156ACC9A8EQ38995161-6C4466CC-0253-4CC8-AA80-8CD5D607B00FQ39300347-9BA3CB02-4B5B-49BB-AA6E-6BE9FF194D6AQ41348682-BCAD5785-288E-48A9-A44E-1FD18E4CC7A4Q42135521-DD9E139F-D68C-4404-9204-322A981303FFQ42772219-881ADB41-2538-400B-9C0C-35EEC2969B96Q46124251-3C630800-0E8B-4525-A78F-916F09A2A157Q46656111-FE21F394-CF34-4FEF-B583-687BE21D9699Q46680285-7AE07F44-508D-4F71-BC00-F134A4949A18Q47342915-E15CD2AD-720B-4260-BB19-BF97735CFF06Q48539185-DC8687EE-FF74-4254-A0FC-D62018F8D45AQ53291938-2CD300C3-E7F6-46B6-B283-2BCA2610232AQ53544744-F22DFE5A-449C-47F3-BE22-8370221BFDB8
P2860
Randomized controlled trial of combined 5-Fluorouracil and low-molecular-weight heparin in the management of unselected rhegmatogenous retinal detachments undergoing primary vitrectomy.
description
2007 nî lūn-bûn
@nan
2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
name
Randomized controlled trial of ...... undergoing primary vitrectomy.
@ast
Randomized controlled trial of ...... undergoing primary vitrectomy.
@en
Randomized controlled trial of ...... undergoing primary vitrectomy.
@nl
type
label
Randomized controlled trial of ...... undergoing primary vitrectomy.
@ast
Randomized controlled trial of ...... undergoing primary vitrectomy.
@en
Randomized controlled trial of ...... undergoing primary vitrectomy.
@nl
prefLabel
Randomized controlled trial of ...... undergoing primary vitrectomy.
@ast
Randomized controlled trial of ...... undergoing primary vitrectomy.
@en
Randomized controlled trial of ...... undergoing primary vitrectomy.
@nl
P2093
P1433
P1476
Randomized controlled trial of ...... undergoing primary vitrectomy.
@en
P2093
P304
P356
10.1016/J.OPHTHA.2006.08.042
P50
P577
2007-04-01T00:00:00Z